Ethiopia vs Saudi Arabia: Prevalence rate of hypertension in women aged 30-79
Ethiopia
30.1
in 2019
Saudi Arabia
30.2
in 2019
Ethiopia rank
156th
Saudi Arabia rank
154th
Prevalence rate of hypertension in women aged 30-79 over time
- Ethiopia
- Saudi Arabia
How they compare
Saudi Arabia currently reports 30.2 against 30.1 in Ethiopia, a difference of 0.1.
Across all 30 years both countries report, Saudi Arabia has been ahead every year.
Ethiopia ranks 156th and Saudi Arabia ranks 154th of 195 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ethiopia | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 26.63 | 34.32 | 7.69 | Saudi Arabia |
| 2000s | 27.24 | 33.93 | 6.69 | Saudi Arabia |
| 2010s | 29.58 | 31.65 | 2.07 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Ethiopia or Saudi Arabia?
- Saudi Arabia, at 30.2 against 30.1 in Ethiopia as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Ethiopia and Saudi Arabia?
- 0.1, with Saudi Arabia ahead.
- How many years of comparable data are there for Ethiopia and Saudi Arabia?
- 30 years are reported by both, from 1990 to 2019.
- How do Ethiopia and Saudi Arabia rank globally for prevalence rate of hypertension in women aged 30-79?
- Ethiopia ranks 156th and Saudi Arabia ranks 154th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.